Medical News

RSS

Students at Penn State College of Medicine celebrate matching with residency programs

Today, 120 fourth-year medical students at Penn State College of Medicine learned where they will spend their residencies in an annual tradition known as Match Day. A similar scene played out with fourth-year students at medical schools across the country.

23 Mar 2015

NNI publishes report on nanotechnology environmental, health, and safety risk science status

The National Nanotechnology Initiative (NNI) today published the report from the workshop, "Stakeholder Perspectives on Perception, Assessment, and Management of the Potential Risks of Nanotechnology" (R3 Workshop), which was held September 10-11, 2013, in Washington, D.C.

23 Mar 2015

EHT expert paper raises important and unanswered questions about safety of wearable tech

Wearable technology is raising health concerns worldwide. A recent New York Times article by Nick Bilton is raising important and unanswered questions about the safety of wearable tech, according to the non-profit research group, Environmental Health Trust.

23 Mar 2015

Point-Person Project may be more successful with a national infrastructure for clinical trials

A study reported in this week's Science Translational Medicine found that qualified investigators are more likely to respond to opportunities for clinical trials if they are contacted by an institution-specific point person, or navigator.

23 Mar 2015

MEI Pharma reports top-line results from Pracinostat Phase II study in patients with high-risk MDS

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, today announced top-line data from a randomized Phase II clinical study of its investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).

23 Mar 2015

OrthoSensor raises $19 million in Series C Preferred Stock financing

OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities.

23 Mar 2015

Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study

Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).

23 Mar 2015

Study: Medical practices need support and guidance to adopt new payment models

Physician practices are engaging in new health care payment models intended to improve quality and reduce costs, but are finding that they need help with successfully managing increasing amounts of data and figuring out how to respond to the diversity of programs and quality metrics from different payers, according to a new joint study by the RAND Corporation and the American Medical Association.

23 Mar 2015

Everyday Health announces acquisition of Cambridge BioMarketing Group

Everyday Health, Inc., a leading provider of digital health and wellness solutions, today acquired Cambridge BioMarketing Group, LLC, the leader in strategic launch and marketing solutions for orphan and rare disease products.

23 Mar 2015

Low-calorie rice could help potentially reduce obesity rates

Scientists have developed a new, simple way to cook rice that could cut the number of calories absorbed by the body by more than half, potentially reducing obesity rates, which is especially important in countries where the food is a staple.

23 Mar 2015

Can-Fite, Cipher Pharmaceuticals sign agreement to distribute CF101 in Canada

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has signed a distribution agreement with Cipher Pharmaceuticals Inc. to distribute Can-Fite's lead drug candidate, CF101, for the treatment of moderate to severe psoriasis and rheumatoid arthritis in the Canadian market upon receipt of regulatory approvals.

23 Mar 2015

Saccharin could potentially lead to development of drugs for difficult-to-treat cancers

Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low, Sweet Twin and Necta, could do far more than just keep our waistlines trim. According to new research, this popular sugar substitute could potentially lead to the development of drugs capable of combating aggressive, difficult-to-treat cancers with fewer side effects.

23 Mar 2015

Acne patients not getting medications prescribed by their dermatologists

Medicine obviously can't do much good if it sits on a pharmacy shelf. Yet more than one-quarter of the acne patients surveyed by Wake Forest Baptist Medical Center researchers didn't get medications prescribed by their dermatologists.

23 Mar 2015

Increased sexual activities may be triggered by media use among boys, but not among girls

There is no doubt that teenage boys and girls are swayed and shaped by music TV. For example, sexually active youth of both genders, after watching music TV, think their peers are sexually active, too.

23 Mar 2015

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

GenVec, Inc. today announced that it has formed a collaboration with TheraBiologics to develop cancer therapeutics leveraging both GenVec's proprietary gene delivery platform and TheraBiologics' proprietary neural stem cell (NSC) technology.

23 Mar 2015

Genetic flaws in bowel cancer may trigger immune response at site of tumours

Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today (Monday) in the journal Oncoimmunology.

23 Mar 2015

Study explores the efficacy of antivenom against copperhead snake bites

Dr. Spencer Greene wants to make sure the standard treatment for copperhead snake bites, the most common venomous snake in greater Houston and southeast Texas, works, and if it doesn't, he wants to stop its use.

23 Mar 2015

Insect-borne diseases increase with warmer climate

Insects, such as mosquitoes and ticks, are responsible for transmitting a range of diseases, such as malaria, chikungunya, dengue fever, and West Nile virus. The risk of contracting such illnesses is generally only considered when booking an exotic holiday. However, experts from the Emergency Response Department at Public Health England have warned that climate change could allow such vector-borne diseases to emerge closer to home.

23 Mar 2015

Study reveals functional heterogeneity of CD4 T cells in immune systems

Utilizing a novel transgenic mouse model, Edward Usherwood, PhD of Dartmouth's Norris Cotton Cancer Center and collaborators found that CD4 T cells divide into two different populations that each has a different job. One type performs antiviral functions, and the other survives life in the host.

23 Mar 2015

MSU scientists identify antioxidant system that backs up liver during crisis

Scientists from Montana State University and Sweden have discovered an antioxidant system that helps sustain the liver when other systems are missing or compromised.

23 Mar 2015

Medical News

Students at Penn State College of Medicine celebrate matching with residency programs

NNI publishes report on nanotechnology environmental, health, and safety risk science status

EHT expert paper raises important and unanswered questions about safety of wearable tech

Point-Person Project may be more successful with a national infrastructure for clinical trials

MEI Pharma reports top-line results from Pracinostat Phase II study in patients with high-risk MDS

OrthoSensor raises $19 million in Series C Preferred Stock financing

Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study

Study: Medical practices need support and guidance to adopt new payment models

Everyday Health announces acquisition of Cambridge BioMarketing Group

Low-calorie rice could help potentially reduce obesity rates

Can-Fite, Cipher Pharmaceuticals sign agreement to distribute CF101 in Canada

Saccharin could potentially lead to development of drugs for difficult-to-treat cancers

Acne patients not getting medications prescribed by their dermatologists

Increased sexual activities may be triggered by media use among boys, but not among girls

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

Genetic flaws in bowel cancer may trigger immune response at site of tumours

Study explores the efficacy of antivenom against copperhead snake bites

Insect-borne diseases increase with warmer climate

Study reveals functional heterogeneity of CD4 T cells in immune systems

MSU scientists identify antioxidant system that backs up liver during crisis

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News